These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6747018)

  • 1. Blood lipid effects of antihypertensive therapy: a double-blind comparison of the effects of methyldopa and propranolol.
    Leon AS; Agre J; McNally C; Bell C; Neibling M; Grimm R; Hunninghake DB
    J Clin Pharmacol; 1984; 24(5-6):209-17. PubMed ID: 6747018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-cholesterol in antihypertensive treatment. The Oslo Study.
    Helgeland A; Leren P; Enger SC; Hjermann I; Holme I
    Acta Med Scand Suppl; 1979; 625():131-4. PubMed ID: 219665
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.
    Dujovne CA; DeCoursey S; Krehbiel P; Jackson B; Chernoff S
    Clin Pharmacol Ther; 1984 Aug; 36(2):157-62. PubMed ID: 6744774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G
    Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the lipoprotein profile during antihypertensive therapy.
    Helgeland A; Leren P; Kjeldsen S; Eide I; Foss OP
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():75-7. PubMed ID: 6711333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
    Misson R; Merkel T; Cutler RE
    Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y
    Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension.
    Zusman R; Christensen D; Federman E; Kochar MS; McCarron D; Porush JG; Spitalewitz S
    Am J Med; 1987 Mar; 82(3B):37-41. PubMed ID: 3551602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum lipid levels during antihypertensive therapy.
    Med J Aust; 1984 Apr; 140(9):522-4. PubMed ID: 6369095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa--a comparison with propranolol.
    VandenBurg MJ; Cooper WD; Woollard ML; Currie WJ; Bowker CH
    Eur J Clin Pharmacol; 1984; 26(3):325-9. PubMed ID: 6734693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prazosin on serum lipids.
    Kokubu T; Itoh I; Kurita H; Ochi T; Murata K; Yuba I
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S228-32. PubMed ID: 6177962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.